» Articles » PMID: 18537133

Estrogen-induced Uterine Abnormalities in TIMP-1 Deficient Mice Are Associated with Elevated Plasmin Activity and Reduced Expression of the Novel Uterine Plasmin Protease Inhibitor Serpinb7

Overview
Journal Mol Reprod Dev
Date 2008 Jun 10
PMID 18537133
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue inhibitor of metalloproteinase-1 (TIMP-1) is a multifunctional protein capable of regulating a variety of biological processes in a wide array of tissue and cell types. We have previously demonstrated that TIMP-1 deficient mice exhibit alterations in normal uterine morphology and physiology. Most notably, absence of TIMP-1 is associated with an altered uterine phenotype characterized by profound branching of the uterine lumen and altered adenogenesis. To begin to assess the mechanism by which TIMP-1 may control these uterine events, we utilized steroid-treated ovariectomized wild-type and TIMP-1 null mice exposed to estrogen for 72 hr. Administration of estrogen to TIMP-1 deficient mice resulted in development of an abnormal uterine histo-architecture characterized by increased endometrial gland density, luminal epithelial cell height, and abnormal lumen structure. To determine the mediators which may contribute to the abnormal uterine morphology in the TIMP-1 deficient mice, cDNA microarray analysis was performed. Analysis revealed that expression of two plasmin inhibitors (serpbinb2 and serbinb7) was significantly reduced in the TIMP-1 null mice. Associated with the reduction in expression of these inhibitors was a significant increase in plasmin activity. Localization of the novel uterine serpinb7 revealed that expression was confined to the luminal and glandular epithelial cells. Further, expression of uterine serpinb7 was decreased by estrogen and showed an inverse relationship with plasmin activity. We conclude from these studies that in addition to controlling MMP activity, TIMP-1 may also control activity of serine proteases through modulation of serine protease inhibitors such as serpinb7.

Citing Articles

Estradiol-17β-Induced Changes in the Porcine Endometrial Transcriptome In Vivo.

Kaczynski P, Bauersachs S, Baryla M, Goryszewska E, Muszak J, Grzegorzewski W Int J Mol Sci. 2020; 21(3).

PMID: 32019139 PMC: 7037416. DOI: 10.3390/ijms21030890.


SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.

Bianconi D, Herac M, Spies D, Kieler M, Brettner R, Unseld M Transl Oncol. 2018; 12(1):15-23.

PMID: 30245304 PMC: 6149193. DOI: 10.1016/j.tranon.2018.08.019.


Maternal serum serpin B7 is associated with early spontaneous preterm birth.

Parry S, Zhang H, Biggio J, Bukowski R, Varner M, Xu Y Am J Obstet Gynecol. 2014; 211(6):678.e1-12.

PMID: 24954659 PMC: 4254341. DOI: 10.1016/j.ajog.2014.06.035.


miR-451 deficiency is associated with altered endometrial fibrinogen alpha chain expression and reduced endometriotic implant establishment in an experimental mouse model.

Nothnick W, Graham A, Holbert J, Weiss M PLoS One. 2014; 9(6):e100336.

PMID: 24937656 PMC: 4061076. DOI: 10.1371/journal.pone.0100336.


Inhibition of macrophage migration inhibitory factor reduces endometriotic implant size in mice with experimentally induced disease.

Nothnick W, Colvin A, Cheng K, Al-Abed Y J Endometr. 2014; 3(3):135-142.

PMID: 24790725 PMC: 4002052.


References
1.
Hulboy D, Wilson C, Mudgett J, Matrisian L . Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice. Endocrinology. 1997; 138(11):4902-11. DOI: 10.1210/endo.138.11.5478. View

2.
Slayden O, Matrisian L, Brenner R . Matrix metalloproteinase expression in Macaca mulatta endometrium: evidence for zone-specific regulatory tissue gradients. Biol Reprod. 1998; 59(6):1349-59. DOI: 10.1095/biolreprod59.6.1349. View

3.
Liu Y, Hu Z, Liu K, Byrne S, Zou R, Ny T . Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes. Placenta. 1998; 19(2-3):171-80. DOI: 10.1016/s0143-4004(98)90006-6. View

4.
Smith R, Xue A, Gill A, Scarlett C, Saxby A, Clarkson A . High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma. World J Surg. 2007; 31(3):493-502. DOI: 10.1007/s00268-006-0289-9. View

5.
Nothnick W . Disruption of the tissue inhibitor of metalloproteinase-1 gene in reproductive-age female mice is associated with estrous cycle stage-specific increases in stromelysin messenger RNA expression and activity. Biol Reprod. 2001; 65(6):1780-8. DOI: 10.1095/biolreprod65.6.1780. View